In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature

BACKGROUND: Epidermal growth factor receptor variant III (EGFRvIII) is a driver mutation and potential therapeutic target in glioblastoma. Non-invasive in vivo EGFRvIII determination, using clinically acquired multiparametric MRI sequences, could assist in assessing spatial heterogeneity related to...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Akbari, Hamed, Bakas, Spyridon, Pisapia, Jared M, Nasrallah, MacLean P, Rozycki, Martin, Martinez-Lage, Maria, Morrissette, Jennifer J D, Dahmane, Nadia, O’Rourke, Donald M, Davatzikos, Christos
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Basic and Translational Investigations
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280148/
https://ncbi.nlm.nih.gov/pubmed/29617843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy033
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia